Loteprednol Etabonate Suspension/ Drops
Product Images NDC 72485-665

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate (NDC 72485-665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

FDA Label Image

Q0 mL Carton Label (Loteprednol Suspension 0.5 10 mL Carton)

FDA Label Image

10 mL Container Label (Loteprednol Suspension 0.5 10 mL Container)

FDA Label Image

15 mL Carton Label (Loteprednol Suspension 0.5 15 mL Carton)

15 mL Carton Label (Loteprednol Suspension 0.5 15 mL Carton)
The text provides information about a medication called Loteprednol Etabonate Ophthalmic Suspension. Each mL of the suspension contains various ingredients such as povidone K-30, sodium hydroxide, tyloxapol, and water for injection. It may also contain hydrochloric acid. The suspension is essentially isotonic and has a tonicity of 250 to 310 m. The preservative added is Benzalkonium chloride. The usual dosage and other important instructions can be found in the package insert. The product should be shaken vigorously before use and should not be frozen. It should only be used if the neckband is intact and imprinted with "sealed for your protection." The product is distributed by Armas Pharmaceuticals, Inc. located in Freehold, NJ. The product has an NDC number of 72485-665-15 and contains 0.5% Loteprednol Etabonate Ophthalmic Suspension.*
FDA Label Image

15 mL Container Label (Loteprednol Suspension 0.5 15 mL Container)

FDA Label Image

5 mL Carton Label (Loteprednol Suspension 0.5 5 mL Carton)

5 mL Carton Label (Loteprednol Suspension 0.5 5 mL Carton)
This text appears to be a description of a medication called Loteprednol Etabonate Ophthalmic Suspension, 0.5%. The medication is used in ophthalmology and each mL of the suspension contains 6 mg (0.6%) of Loteprednal Etabonate as the active ingredient. The suspension also contains various inactive ingredients such as edatate disodium, glycerin, and povidone K-30, among others. The pH of the suspension may be adjusted using hydrochloric acid. The suspension is essentially isotonic and comes with a tonicity of 250 to 310 mOsmol/kg. Benzalkonium chloride is added as a preservative in a concentration of 0.01%. The usual dosage is mentioned to be provided in the package insert. It is important to shake the suspension vigorously before using. The medication is distributed by Amas Pharmaceuticals, Inc. and the storage instructions recommend keeping it upright between 15°-25°C (68°-77°F) without freezing it. The medication is for ophthalmic use only and should be kept out of reach of children. The Loteprednol Etabonate Ophthalmic Suspension, 0.5% is packaged in a 5mL container. The packaging also states that it is a sterile ophthalmic suspension. The neckband of the packaging should have the imprint "SEALED FOR YOUR PROTECTION". The text also mentions that the medication is made in Switzerland by Sentiss and the revision is labeled as 0823.*
FDA Label Image

5 mL Container Label (Loteprednol Suspension 0.5 5 mL Container)

5 mL Container Label (Loteprednol Suspension 0.5 5 mL Container)
This text appears to be a description of a pharmaceutical product. The product is a suspension containing Loteprednol Etabonate, with a concentration of 5mg (0.5%) per mL. The recommended usage and storage instructions are not readable due to errors. The product is distributed by Armas Pharmaceuticals, Inc. and manufactured in Switzerland. The text also includes a reference number (MOC7248585605) and a revision number (Rev. 08723).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.